CORC

浏览/检索结果: 共25条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18
作者:  Li, Ning;  Zhu, Jianqing;  Yin, Rutie;  Wang, Jing;  Pan, Lingya
收藏  |  浏览/下载:15/0  |  提交时间:2022/12/23
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
收藏  |  浏览/下载:25/0  |  提交时间:2022/12/22
Exploratory hrd and PD-L1 analysis of l-MOCA study: Olaparib maintenance monotherapy in Asian patients with platinum-sensitive relapsed ovarian cancer. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Ma, Ding;  Gao, Qing-Lei;  Zhu, Jianqing;  Zhao, Weidong;  Huang, Yi
收藏  |  浏览/下载:20/0  |  提交时间:2022/12/23
Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Yin, Rutie;  Li, Ning;  Wu, Lingying;  Wang, Jing;  Zhu, Jianqing
收藏  |  浏览/下载:17/0  |  提交时间:2022/12/23
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022
作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge
收藏  |  浏览/下载:28/0  |  提交时间:2022/05/05
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Jing;  Lin, Zhongqiu;  Yin, Rutie
收藏  |  浏览/下载:100/0  |  提交时间:2022/03/28
Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
收藏  |  浏览/下载:45/0  |  提交时间:2021/11/01
Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wang, Jing;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin
收藏  |  浏览/下载:22/0  |  提交时间:2022/01/10
L-MOCA: An open-label study of olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Gao, Qing-Lei;  Zhu, Jianqing;  Zhao, Weidong;  Huang, Yi;  An, Ruifang
收藏  |  浏览/下载:26/0  |  提交时间:2022/01/10
Efficacy of niraparib maintenance therapy in Chinese women with platinum-sensitive recurrent ovarian cancer with and without secondary cytoreductive surgery: Results from the NORA trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wu, Lingying;  Wu, Xiaohua;  Zhu, Jianqing;  Yin, Rutie;  Yang, Jiaxin
收藏  |  浏览/下载:21/0  |  提交时间:2022/01/10


©版权所有 ©2017 CSpace - Powered by CSpace